Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Observational 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Colorectal Neoplasms 30Carcinoma, Non-Small-Cell Lung 9Breast Neoplasms 7Carcinoma, Renal Cell 6Carcinoma, Hepatocellular 6Lung Neoplasms 5Ovarian Neoplasms 4Colorectal Cancer Metastatic 3Colonic Neoplasms 3Adenocarcinoma of Lung 3Rectal Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Liver Neoplasms 2Financial Stress 2Brain Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Unspecified Adult Solid Tumor, Protocol Specific 1Unresectable Hepatocellular Carcinoma 1Surgical Wound Infection 1Non-Squamous Non-Small Cell Lung Cancer 1Neuroma, Acoustic 1Neurofibromatosis 2 1NSCLC 1Melanoma 1Kidney Neoplasms 1Hypertension 1Hemorrhage 1Glioblastoma 1Feasibility 1

Interventions

Surveys and Questionnaires 3pazopanib 2Sunitinib 2Sorafenib 2Bevacizumab 2Patient Reported Outcome Measures 1Medical Records 1Data Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Financial Stress × Bevacizumab × Clear all
NCT01381601 2013-05-13

Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)

GlaxoSmithKline

Completed
1 enrolled
Genitourinary

Financial Stress, Carcinoma, Renal Cell

NCT01381614 2013-05-13

Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)

GlaxoSmithKline

Completed
1 enrolled
Genitourinary

Financial Stress, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡